12 Sept 2012

Cancer Research opportunity for Physicians: Silchar, Assam

Cancer Research opportunity for Physicians: Silchar, Assam, India

We have an immediate opening for a JRF position leading to PhD in a DBT (Gov. of India) funded project on nasopharyngeal cancer.

We would like to encourage the participation of clinicians in the field of research by offering them the opportunity to do research in cancer biology apart from their routine clinical work.

For Physicians (MBBS/MD/MS) or basic science postgraduate (MSc/B.Tech/M.Tech in Biological stream) interested in a research career in cancer, we may offer through Dept. of Biotechnology, Assam University (A Central University) the PhD program in cancer.

Physicians (MBBS/MD/MS) will have the opportunity to be trained in comprehensive cancer management under renowned super specialists along with the opportunity of conducting high impact research. Generous clinical assistantships are available for the selected applicant having MBBS/MD/MS qualification in addition to their research fellowship.

Cachar Cancer Hospital and Research Centre (CCHRC), a comprehensive cancer center sees more than 4000 new and 10000 follow-up cancer patients annually and serves an underserved and economically impoverished community of patients from the districts of Assam state and from the states of Tripura, Manipur, Mizoram and other parts of India. It has a well-developed Dept. of Molecular Oncology with a range of facilities like Flow Cytometer, Chemiluminescence, IHC for research. We also have collaboration with INDOX (University of Oxford Consortium).

Silchar is a peaceful and quit place in Assam state of India full of tea gardens and natural sceneries. If you are tired from big cities and if you would like to live a stress free life, this is the place.

Those who are interested should send their latest CV along with covering letter mentioning why they want to pursue career in cancer research by email to ravi.kannan@cacharcancerhospital.org and rajeev.kvhfc@cacharcancerhospital.org on or before October 15, 2012.

No comments:

Post a Comment